Table 1.
DMVhi cohort age-group and gender-specific prevalence rates of undiagnosed type 2 diabetes, impaired glucose tolerance and impaired fasting glucose (n = 29,144; male = 12,929 (44%); female = 16,215 (56%)).
Fig 1.
Results of DMVhi screening for undiagnosed type 2 diabetes, impaired fasting glucose and impaired glucose tolerance (March 2009-December 2012).
RFG = repeat fasting glucose, IGT = impaired glucose tolerance, IFG = impaired fasting glucose, OGTT = oral glucose tolerance test. *Participants were not deemed to have completed screening if they did not return for required OGTT/RFG (n = 322) or did not provide a venous fasting sample (n = 82). ** Diagnosed with diabetes on fasting blood glucose (≥7.0 mmol/L) and symptoms of diabetes.
Table 2.
DMVhi study participant characteristics by glucose tolerance status (n = 29,144).
Table 3.
Multivariable-adjusted odds ratios and 95% confidence intervals for having undiagnosed T2D, impaired glucose tolerance and impaired fasting glucose (compared with normoglycaemia) in the DMVhi study cohort.